Product Reports Resources Pricing Login Book a demo

Athelas

Biotech & Life Sciences · Mountain View, United States · Founded 2016

Provides healthcare products and medical billing services

Investors

16 investors on Athelas's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage
Aravis Ventures
VI Partners
Novartis Venture Fund

Global footprint

Where Athelas has talent and traffic

Workforce by country
11 countries with
team presence
🇺🇸 United States89.4%
🇮🇳 India7%
🇧🇷 Brazil1.4%
🇧🇩 Bangladesh0.3%
🇪🇸 Spain0.3%
Top 5 of 11 shown
Web traffic by country
340K monthly visits
across markets
🇺🇸 United States97.9%
🇬🇧 United Kingdom0.7%
🇮🇳 India0.6%
🇨🇦 Canada0.4%
🇮🇩 Indonesia0.4%
Top 5 markets shown

Talent graph

The shape of Athelas's talent

Dealroom maps Athelas's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

10 standout operatorsDealroom-flagged across the org
5 AI specialistsincl. 1 core researchers
336 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Athelas's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$274k patent portfolio · 3 active families

Estimated portfolio value
$274k
0.02% of valuation · 85.5× smaller than top peer Recursion Pharma ($23M)
3 active patent families
Where Athelas innovates Cell typeCell type specificCell typingChemistryDisplay device

Where Athelas concentrates vs peers

Each axis is a top-10 topic across Athelas and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Athelas

An AI-synthesized read of the highest-engagement posts about Athelas on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Athelas on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.